| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |